Halozyme Surf Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $400M

Halozyme Surf Bio General Information

Description

Developer of a novel biotechnology platform designed to improve drug effectiveness. The company's platform is used to develop improved therapeutic applications for diabetes, oncology, HIV, COVID-19, and other disease states, enabling healthcare organizations across the world to have access to new and improved drugs that can be administered to patients suffering from critical diseases.

Contact Information

Website
www.surf.bio
Formerly Known As
Surf Bio
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 505 Hamilton Avenue
  • Suite 300
  • Palo Alto, CA 94301
  • United States
Primary Industry
Drug Delivery
Parent Company
Vertical(s)
Corporate Office
  • 505 Hamilton Avenue
  • Suite 300
  • Palo Alto, CA 94301
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Halozyme Surf Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 22-Dec-2025 $400M Completed Generating Revenue
2. Grant 30-Apr-2024 Completed Generating Revenue
1. Seed Round 12-Apr-2022 $16M $16M Completed Generating Revenue
To view Halozyme Surf Bio’s complete valuation and funding history, request access »

Halozyme Surf Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed
To view Halozyme Surf Bio’s complete cap table history, request access »

Halozyme Surf Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel biotechnology platform designed to improve drug effectiveness. The company's platform is used to de
Drug Delivery
Palo Alto, CA
6 As of 2026

Rockville, MD

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Halozyme Surf Bio Competitors (36)

One of Halozyme Surf Bio’s 36 competitors is ReveraGen BioPharma, a Formerly VC-backed company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ReveraGen BioPharma Formerly VC-backed Rockville, MD
Cidara Therapeutics Formerly VC-backed San Diego, CA
Centrose Venture Capital-Backed Madison, WI
Synthon International Holding Private Equity-Backed Nijmegen, Netherlands
Regenxbio Formerly VC-backed Rockville, MD
You’re viewing 5 of 36 competitors. Get the full list »

Halozyme Surf Bio Patents

Halozyme Surf Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026011155-A1 Injectable polymeric biopharmaceutical formulations Pending 04-Jul-2024
EP-4791356-A1 Solid polyacrylamide polymer biopharmaceutical formulations Pending 15-Oct-2023
WO-2025085401-A1 Solid polyacrylamide polymer biopharmaceutical formulations Inactive 15-Oct-2023
EP-4529550-A1 Polymer excipients comprising n,n-diethylacrylamide (dea) for biopharmaceutical formulations Pending 23-May-2022
WO-2023230046-A1 Polymer excipients comprising n,n-diethylacrylamide (dea) for biopharmaceutical formulations Inactive 23-May-2022 C08L33/24
To view Halozyme Surf Bio’s complete patent history, request access »

Halozyme Surf Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Halozyme Surf Bio Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Breakout Ventures Venture Capital Minority
Gates Foundation Not-For-Profit Venture Capital
Perceptive Advisors Venture Capital Minority
Xontogeny Accelerator/Incubator Minority
To view Halozyme Surf Bio’s complete investors history, request access »

Halozyme Surf Bio FAQs

  • When was Halozyme Surf Bio founded?

    Halozyme Surf Bio was founded in 2021.

  • Where is Halozyme Surf Bio headquartered?

    Halozyme Surf Bio is headquartered in Palo Alto, CA.

  • What is the size of Halozyme Surf Bio?

    Halozyme Surf Bio has 6 total employees.

  • What industry is Halozyme Surf Bio in?

    Halozyme Surf Bio’s primary industry is Drug Delivery.

  • Is Halozyme Surf Bio a private or public company?

    Halozyme Surf Bio is a Private company.

  • What is the current valuation of Halozyme Surf Bio?

    The current valuation of Halozyme Surf Bio is .

  • What is Halozyme Surf Bio’s current revenue?

    The current revenue for Halozyme Surf Bio is .

  • How much funding has Halozyme Surf Bio raised over time?

    Halozyme Surf Bio has raised $16M.

  • Who are Halozyme Surf Bio’s investors?

    Breakout Ventures, Gates Foundation, Perceptive Advisors, and Xontogeny have invested in Halozyme Surf Bio.

  • Who are Halozyme Surf Bio’s competitors?

    ReveraGen BioPharma, Cidara Therapeutics, Centrose, Synthon International Holding, and Regenxbio are some of the 36 competitors of Halozyme Surf Bio.

  • When was Halozyme Surf Bio acquired?

    Halozyme Surf Bio was acquired on 22-Dec-2025.

  • Who acquired Halozyme Surf Bio?

    Halozyme Surf Bio was acquired by Halozyme Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process